Pure Global AI
Singapore flag

Singapore medical device registration timeline

Source-linked clocks

Health Sciences Authority (HSA) review clocks and end-to-end planning ranges, using the 4-class (A, B, C, D) classification system.

4 pathways4 of 4 clocks verifiedvalidity No fixed term. A Class B, C or D entry stays in the Singapore Medical Device Register for as long as the annual retention fee is paid before the deadline.MDSAP acceptedreviewed 2026-08-30hsa.gov.sg
Class / pathwayReview clockPlanning totalWith prior approvalProvenance
Class A(Notification)
Class A is exempt from product registration
ImmediateImmediate—Verified
Class B(IBR/Expedited/Full Route)
Four Class B routes, and which one applies is decided by how many reference approvals the device already holds rather than by choice: Immediate Class B Registration is granted on submission, abridged takes 100 working days, full takes 160, and full under the Priority Review Scheme takes 104
0-160 working days3-9 monthsImmediateVerified
Class C(IBR/Expedited/Full Route)
Five Class C routes: an immediate route confined to standalone medical mobile applications, expedited (ECR) at 120 working days, abridged at 160, full at 220, and full under the Priority Review Scheme at 143
0-220 working days6-12 monthsImmediateVerified
Class D(IBR/Expedited/Full Route)
Four Class D routes: expedited (EDR) at 180 working days, abridged at 220, full at 310, and full under the Priority Review Scheme at 202. There is no immediate route at Class D
180-310 working days9-18 months6-12 monthsVerified
Review clocks exclude applicant hold time · planning totals are estimates

Singapore Medical Device Registration Process

Step-by-step HSA registration process. Total estimated timeline: Immediate.

Step 1: Pre-Submission Preparation

1-3 months

Gather technical documentation, quality management system (QMS) records, and clinical data required by HSA. Appoint a Singapore Product Registrant.

Step 2: Application Submission

1-2 weeks

Submit complete registration dossier to HSA including device description, risk analysis, and testing reports.

Step 3: Administrative Review

2-4 weeks

HSA reviews application for completeness. May request additional documents or clarifications.

Step 4: Technical Evaluation

Immediate

In-depth technical assessment of device safety and performance. HSA may issue questions.

Step 5: Registration Approval

1-2 weeks

Upon successful review, HSA issues Singapore market authorization certificate.

Summary: The Singapore medical device registration process through Health Sciences Authority (HSA) consists of 5 main steps: Pre-Submission Preparation → Application Submission → Administrative Review → Technical Evaluation → Registration Approval.
Expedited pathways
Immediate Class B Registration (IBR)Immediate upon submission, against 100 working days abridged or 160 full

Registration granted on submission for a Class B device with either one reference approval plus three years of marketing in that jurisdiction, or two reference approvals. Also open, on one reference approval and no marketing history, to standalone medical mobile applications at Class B and Class C.

Eligibility: Class B device, or a standalone medical mobile application at Class B or C, One reference approval with three years of marketing there, or two reference approvals, No global safety issue and no prior rejection or withdrawal by HSA or a reference agency

Expedited Class C (ECR) and Class D (EDR) registrationClass C 120 working days against 220 full; Class D 180 against 310

A shorter evaluation for devices already cleared by HSA reference agencies. ECR-1 needs one reference approval plus three years of marketing there; ECR-2 and EDR need two reference approvals.

Eligibility: Class C or Class D device not on the excluded list, One reference approval with three years of marketing, or two reference approvals, No prior rejection or withdrawal by HSA or a reference agency

Abridged routeClass B 100 working days against 160; Class C and D 160 and 220 against 220 and 310

The baseline reliance route: any single reference approval moves a device off the full evaluation. A device with no reference approval must go full route.

Eligibility: Approval from at least one HSA overseas reference regulatory agency for the same labelled use

Priority Review SchemeClass B 104 working days against 160, Class C 143 against 220, Class D 202 against 310

The one route that does not depend on a foreign approval. It is available only on the full evaluation route and cuts the turnaround by 35%. Route 1 is for devices in oncology, diabetes, ophthalmic, cardiovascular, infectious or skin disease that meet an unmet clinical need; Route 2 is for everything else and costs more.

Eligibility: Class B, C or D on the full evaluation route, Class D with a registrable drug in a secondary role is excluded

Prior approval recognition
Two reference approvals (any two of US FDA, EU Notified Body, Health Canada, Australia TGA, Japan MHLW)At Class B this is the IBR trigger and registration is granted on submission. At Class C and D it is the ECR-2 or EDR trigger.Class B immediate against 160 working days; Class C 120 against 220; Class D 180 against 310
FDA 510(k)/De Novo/PMAA single US clearance qualifies the device for the abridged route, and for IBR or ECR-1 if it has also been marketed in the US for three years.Class B 100 working days against 160; Class C 160 against 220; Class D 220 against 310
EU CE MarkQualifies for the abridged route on the same terms, but only via the specific EC certificate routes HSA lists — a self-declared Class I CE mark does not count, and neither does a reference-agency Class I or Class II exempt classification.Class B 100 working days against 160; Class C 160 against 220; Class D 220 against 310
Health Canada, Australia TGA, Japan MHLWA Canadian or Australian device registration licence, or a Japanese Ninsho certification or Shonin approval, counts as a reference approval on the same terms as the US and EU.Same as the abridged route figures above; two of them together trigger IBR, ECR-2 or EDR
Key requirements
  • Singapore Product Registrant (for foreign manufacturers)
  • PRISM registration
  • English labeling (no translation required)
  • Change of registrant: 40 working days; importer, wholesaler or manufacturer dealer licence, whether new, annual renewal or amendment: 10 working days; free sale or export certificate: 14 working days; Special Access Route application: 14 working days
  • Change notifications carry their own clocks: administrative changes 30 working days at every class; Class B review changes 45; Class C technical changes 75; Class D technical changes 90
  • Class B, C and D registrations must be retained annually in the Singapore Medical Device Register — the entry stays live on payment of the retention fee before the deadline, so lapsing the fee, not an expiry date, is what ends a registration
  • All published HSA turnaround times exclude the applicant stop-clock for responding to HSA requests for additional information

MDSAP: Accepted for QMS evidence

Primary regulator sources
hsa.gov.sg · HSA medical device registration overview hsa.gov.sg · HSA fees and turnaround time for medical devices hsa.gov.sg · HSA Priority Review Scheme for medical devices

Reviewed 2026-08-30. End-to-end totals remain planning estimates.

Keep researching this market

More Singapore medical device resources

View the Singapore resource hub →
Compare timeline across all countries →
Continue with this market
Source-linked review clocks verified against HSA publications · full review 2026-08-30 · row IDs are stable — cite as registration-timeline:singapore:class-a